1. 124 AZACITIDINE VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML (>30% MARROW BLASTS) WITH MYELODYSPLASIA-RELATED CHANGES: SUBGROUP ANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Seymour, J.F.; Döhner, H.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 96 OVERALL SURVIVAL IN OLDER PATIENTS WITH NEWLY DIAGNOSED AML WITH >30% BONE MARROW BLASTS AND POOR-RISK CYTOGENETICS TREATED WITH AZACITIDINE: SUBANALYSIS OF THE AZA-AML-001 STUDY. (April 2015) Authors: Döhner, H.; Seymour, J.F.; Butrym, A.; Wierzbowska, A.; Selleslag, D.; Jang, J.H.; Cavenagh, J.D.; Kumar, R.; Schuh, A.C.; Candoni, A.; Récher, C.; Sandhu, I.; del Castillo, T. Bernal; Al-Ali, H.K.; Martinelli, G.; Falantes, J.; Nopenney, R.; Stone, R.M.; Minden, M.D.; McIntyre, H. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction. Issue 3 (March 2015) Authors: Ramos, F.; Thépot, S.; Pleyer, L.; Maurillo, L.; Itzykson, R.; Bargay, J.; Stauder, R.; Venditti, A.; Seegers, V.; Martínez-Robles, V.; Burgstaller, S.; Récher, C.; Debén, G.; Gaidano, G.; Gardin, C.; Musto, P.; Greil, R.; Sánchez-Guijo, F.; Fenaux, P.; for the European ALMA Investigators, 1 Journal: Leukemia research Issue: Volume 39:Issue 3(2015:Mar.) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Issue 7 (7th June 2021) Authors: Fodil, S.; Raffoux, E.; Dumas, P. Y.; Desbrosses, Y.; Larosa, F.; Chantepie, S.; Larcher, M. V.; Mear, J. B.; Peterlin, P.; Hunault-Berger, M.; Hospital, M. A.; Morel, V.; Lucas, N.; Vidal, V.; Salanoubat, C.; Michel, J.; Mediavilla, C.; Ojeda-Uribe, M.; Alexis, M.; Frayfer, J. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 7(2021) Page Start: 1756 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P421: LOWER VΓ9VΔ2 T CELLS RELATIVE FREQUENCIES PREDICT POORER SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Le Floch, A.-C.; Orlanducci, F.; Le Roy, A.; Hamel, J.-F.; Ifrah, N.; Cornillet-Lefebvre, P.; Delaunay, J.; Récher, C.; Delabesse, E.; Pigneux, A.; Béné, M.-C.; Vey, N.; Chretien, A.-S.; Olive, D. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study. Issue 1 (December 2016) Authors: Lamy, S.; Bettiol, C.; Grosclaude, P.; Compaci, G.; Albertus, G; Récher, C.; Nogaro, J.; Despas, F.; Laurent, G.; Delpierre, C. Journal: BMC health services research Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗